Neurological Biomarker Market to Grow at a CAGR of 13.0% to reach US$ 5,501.8 million from 2020 to 2027

Neurological Biomarker Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Others); Application (Alzheimer's Disease, Parkinson's Disease, Schizophrenia, Huntington's Disease, Spinal Muscular Atrophy, Others); End User (Pharmaceutical and Biotechnology Companies, Clinical Diagnostics, Research Organizations) and Geography

Publication Month: Jun 2020 | Report Code: TIPRE00003515 | No. of Pages: 168 | Category: Biotechnology | Status: Published
Covid

The neurological biomarker market is expected to reach US$ 5,501.8 million by 2027 from US$ 14,454.7 million in 2019. The market is estimated to grow at a CAGR of 13.0% from 2020 to 2027.

 

Biomarkers are disease-specific molecular indicators. In early days,the neurological disease biomarkers were not that accessible; however, the advancements in the technology have enabled the measurement of specific biomarkers for tracking the health of the brain. This helps in the early detection of a disease and less invasive diagnostics, and enables faster drug development.The global neurological biomarker market is driven by factors such as the increasing prevalence of neurological diseases and growing focus on neurological biomarker research are expected to propel the growth of the market during the forecast period. However, the concerns associated with biomarker like measurement errors, cost and othershamper the market growth. Additionally, increasing awareness about neurological diseases, coupled with developing healthcare infrastructure, are creating growth opportunities for the market players.

 

Lucrative Regional Markets for Neurological Biomarkers

Lucrative Regional Markets for Neurological Biomarkers

Get more information on this report :


Market Insights

Growing Focus on Neurological Biomarker Research

Rapid developments in healthcare and drug discovery sector are leading to the introduction of new therapeutic solutions for the treatment of neurological diseases. Authorities such as World Health Organization, National Institute of Neurological Disorders and Stroke, and National Institutes of Health are taking constructive steps to encourage the research activities and find a remedy for neurological disease treatment.

 

A biomarker is an indicator of normal biological processes, pathogenic processes, or evaluating a therapeutic intervention. Thus, the discovery of biomarker is an active research area, where a few biomarkers have been sufficiently studied and validated for its use in clinical practice and clinical trials.

 

The National Institute of Neurological Disorders and Stroke (NINDS) biomarker program is focused on enhancing the quality and efficiency of neurotherapeutic clinical research and supports the biomarker validation.  The program promotes rigorous biomarker identification and validation by providing funds for the research activities. Similarly, Parkinson’s Disease Biomarkers Program (PDBP) was initiated to support new and existing research promoting the discovery of biomarker for Parkinson's disease.

 

Product-BasedInsights

Based on product, the global neurological biomarker market is segmented into proteomics biomarker, genomics biomarker, metabolomics biomarker, imaging biomarker, and others. In 2019, the genomic biomarkers held the largest share of the market, and the market for the same is expected to grow at the fastest CAGR during the forecast period. This lucrative growth of the market for genomic biomarkers is attributed to increasing awareness among consumers regarding the benefits of genetic medicines as well as technological advancements in the field of neurological biomarkers. In addition, the shift in preference toward gene counseling and genetic analysis for diagnostic purposes is also likely to fuel the growth of the segmental market. The genetic biomarkers are significant modalities that directs toward a more personalized approach for predispositions and medical analysis.

 

Global Neurological Biomarker Market, by Product– 2018 and 2027

Global Neurological Biomarker Market

Get more information on this report :



Application-Based Insights

The global neurological biomarker market, based on application,is segmented into Alzheimer's disease, Parkinson's disease, schizophrenia, Huntington's disease, spinal muscular atrophy, and others. The Alzheimer's diseasesegment held the greatest share of the market in 2019. Moreover, it is also estimated to register the highest CAGR in the marketduring 2020–2027.

 

End User-Based Insights

On the basis of enduser, the neurological biomarkermarket has been segmented into pharmaceutical and biotechnology companies, clinical diagnostics, and research organizations.In 2019, the pharmaceutical and biotechnology companiessegment held the largest share of the market, and it is further expected to register the highest CAGR during 2020–2027.

 

Strategic Insights

Product launches and approvalsare the commonly adopted strategies by companies to expand their global footprintsand product portfolios, which helps them meet the growing consumer demand. Collaboration is one of the major strategies adopted by the neurological biomarker marketplayers to enlarge customer base worldwide, which also permits them to maintain their brand name globally.

 

Global Neurological BiomarkerMarket– ByProduct

  • Proteomics Biomarker
  • Genomics Biomarker
  • Metabolomics Biomarker
  • Imaging Biomarker
  • Others


Global Neurological BiomarkerMarket– By Application

  • Alzheimer's Disease
  • Parkinson's Disease
  • Schizophrenia
  • Huntington's Disease
  • Spinal Muscular Atrophy
  • Others


Global Neurological BiomarkerMarket– By End User

  • Pharmaceutical and Biotechnology Companies
  • Clinical Diagnostics
  • Research Organizations

 

Neurological BiomarkerMarket – By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South and Central America
    • Brazil
    • Argentina
    • Rest of South America

 

Company Profiles

  • Thermo Fisher Scientific Inc.
  • Abbott
  • Myriad Genetics Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen Banyan Biomarkers Inc.
  • Immunarray Pvt. Ltd.
  • Quest Diagnostics Incorporated
  • PerkinElmer, Inc.
  • Merck Millipore

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Neurological Biomarker Market – By Product

1.3.2        Neurological Biomarker Market – By Application

1.3.3        Neurological Biomarker Market – By End User

1.3.4        Global Neurological Biomarker Market – By Geography

2.             Neurological Biomarker Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Neurological Biomarker Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia Pacific– PEST Analysis

4.2.4        Middle East and Africa – PEST Analysis

4.2.5        South & Central America

4.3       Expert Opinion

5.             Neurological Biomarker Market – Key Market Dynamics

5.1       Key Market Drivers

5.1.1        Rising Prevalence of Neurological Diseases

5.1.2        Growing Focus on Neurological Biomarker Research

5.2       Key Market Restraints

5.2.1        Concerns Associated with Biomarkers

5.3       Key Market Opportunities

5.3.1        Increasing Awareness of Neurological Diseases Coupled with Developing Healthcare Infrastructure

5.4       Future Trends

5.4.1        The Rising Trend of Precision/Personalized Healthcare

5.5       Impact analysis

6.             Neurological Biomarker Market – Global Analysis

6.1       Global Neurological Biomarker Market Revenue Forecast And Analysis

6.2       Global Neurological Biomarker Market, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

7.             Neurological Biomarker Market Analysis– by Product

7.1       Overview

7.2       Neurological Biomarker Market Share, By Product, 2019 & 2027 (%)

7.2.1        Neurological Biomarker Market Revenue and Forecasts to 2027, By Product(US$ Mn)

7.3       Proteomics Biomarker

7.3.1        Overview

7.3.2        Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.4       Genomics Biomarker

7.4.1        Overview

7.4.2        Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.5       Metabolomics Biomarker

7.5.1        Overview

7.5.2        Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.6       Imaging Biomarker

7.6.1        Overview

7.6.2        Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.7       Others

7.7.1        Overview

7.7.2        Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.             Neurological Biomarker Market Analysis– by Application

8.1       Overview

8.2       Neurological Biomarker Market Share, By Application, 2019 & 2027 (%)

8.2.1        Neurological Biomarker Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3       Alzheimer’s Disease

8.3.1        Overview

8.3.2        Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.4       Parkinson’s Disease

8.4.1        Overview

8.4.2        Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.5       Schizophrenia

8.5.1        Overview

8.5.2        Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)

8.6       Huntington's Disease

8.6.1        Overview

8.6.2        Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.7       Spinal Muscular Atrophy

8.7.1        Overview

8.7.2        Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)

8.8       Others

8.8.1        Overview

8.8.2        Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.             Neurological Biomarker Market Analysis– by End User

9.1       Overview

9.2       Neurological Biomarker Market Share, By End User, 2019 & 2027 (%)

9.2.1        Neurological Biomarker Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.3       Pharmaceutical and Biotechnology Companies

9.3.1        Overview

9.3.2        Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4       Clinical Diagnostics

9.4.1        Overview

9.4.2        Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

9.5       Research Organizations

9.5.1        Overview

9.5.2        Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

10.          Neurological Biomarker Market Analysis And Forecasts To 2027 – Geographical Analysis

10.1    North America: Neurological Biomarker Market

10.1.1     Overview

10.1.2     North America: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.3     North America: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.4     North America: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.5     North America: Neurological Biomarker Market, by End-User , 2018–2027 (USD Million)

10.1.6     North America: Neurological Biomarker Market, by Country, 2019& 2027 (%)

10.1.7     US: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1    US: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2    US: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.7.3    US: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.7.4    US: Neurological Biomarker Market, by End-User , 2018–2027 (USD Million)

10.1.8     Canada: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1    Canada: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2    Canada: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.8.3    Canada: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.8.4    Canada: Neurological Biomarker Market, by End-User , 2018–2027 (USD Million)

10.1.9     Mexico: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1    Mexico: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2    Mexico: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.9.3    Mexico: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.9.4    Mexico: Neurological Biomarker Market, by End-User , 2018–2027 (USD Million)

10.2    Europe: Neurological Biomarker Market

10.2.1     Overview

10.2.2     Europe: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)

10.2.3     Europe: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.2.4     Europe: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.2.5     Europe: Neurological Biomarker Market, by End-User , 2018–2027 (USD Million)

10.2.6     Europe: Neurological Biomarker Market, by Country, 2019& 2027 (%)

10.2.7     Germany: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.1    Germany: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.2    Germany: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.2.7.3    Germany: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.2.7.4    Germany: Neurological Biomarker Market, by End-User , 2018–2027 (USD Million)

10.2.8     United Kingdom: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.1    United Kingdom: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.2    United Kingdom: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.2.8.3    United Kingdom: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.2.8.4    United Kingdom: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.2.9     France: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.1    France: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.2    France: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.2.9.3    France: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.2.9.4    France: Neurological Biomarker Market, by End-User , 2018–2027 (USD Million)

10.2.10   Spain: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.1 Spain: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.2 Spain: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.2.10.3 Spain: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.2.10.4 Spain: Neurological Biomarker Market, by End-User , 2018–2027 (USD Million)

10.2.11   Italy: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.1 Italy: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.2 Italy: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.2.11.3 Italy: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.2.11.4 Italy: Neurological Biomarker Market, by End-User , 2018–2027 (USD Million)

10.3    Asia Pacific: Neurological Biomarker Market

10.3.1     Overview

10.3.2     Asia Pacific: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)

10.3.3     Asia Pacific: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.3.4     Asia Pacific: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.3.5     Asia Pacific: Neurological Biomarker Market, by End-User , 2018–2027 (USD Million)

10.3.6     Asia Pacific: Neurological Biomarker Market, by Country, 2019& 2027 (%)

10.3.7     China: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.3.7.1    China: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.3.7.2    China: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.3.7.3    China: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.3.7.4    China: Neurological Biomarker Market, by End-User , 2018–2027 (USD Million)

10.3.8     Japan: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.1    Japan: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.2    Japan: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.3.8.3    Japan: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.3.8.4    Japan: Neurological Biomarker Market, by End-User , 2018–2027 (USD Million)

10.3.9     India: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.1    India: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.2    India: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.3.9.3    India: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.3.9.4    India: Neurological Biomarker Market, by End User, 2018–2027 (USD Million)

10.3.10   South Korea: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.1 South Korea: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.2 South Korea: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.3.10.3 South Korea: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.3.10.4 South Korea: Neurological Biomarker Market, by End User, 2018–2027 (USD Million)

10.3.11   Australia: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.1 Australia: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.2 Australia: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.3.11.3 Australia: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.3.11.4 Australia: Neurological Biomarker Market, by End User, 2018–2027 (USD Million)

10.4    Middle East and Africa: Neurological Biomarker Market

10.4.1     Overview

10.4.2     Middle East and Africa: Neurological Biomarker Market- Revenue and Forecast to 2027 (USD Million)

10.4.3     Middle East and Africa: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.4.4     Middle East and Africa: Neurological Biomarker Market, by Application, 2018–2027 (Million Units)

10.4.5     Middle East and Africa: Neurological Biomarker, Market, by End User, 2018–2027 (USD Million)

10.4.6     Middle East and Africa: Neurological Biomarker Market, by Country, 2019 & 2027 (%)

10.4.7     Saudi Arabia: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

10.4.7.1    Saudi Arabia: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

10.4.7.2    Saudi Arabia: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.4.7.3    Saudi Arabia: Neurological Biomarker Market, by Application, 2018–2027 (Million Units)

10.4.7.4    Saudi Arabia: Neurological Biomarker, Market, by End User, 2018–2027 (USD Million)

10.4.8     UAE: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

10.4.8.1    UAE: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

10.4.8.2    UAE: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.4.8.3    UAE: Neurological Biomarker Market, by Application, 2018–2027 (Million Units)

10.4.8.4    UAE: Neurological Biomarker, Market, by End User, 2018–2027 (USD Million)

10.4.9     South Africa: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

10.4.9.1    South Africa: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

10.4.9.2    South Africa: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.4.9.3    South Africa: Neurological Biomarker Market, by Application, 2018–2027 (Million Units)

10.4.9.4    South Africa: Neurological Biomarker, Market, by End User, 2018–2027 (USD Million)

10.5    South and Central America: Neurological Biomarker Market

10.5.1     Overview

10.5.2     South and Central America: Neurological Biomarker Market - Revenue and Forecast to 2027  (US$ Million)

10.5.3     South and Central America: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.5.4     South and Central America: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.5.5     South and Central America: Neurological Biomarker Market, by End User, 2018–2027 (USD Million)

10.5.6     South and Central America: Neurological Biomarker Market, by Country, 2019 & 2027 (%)

10.5.7     Brazil: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.1    Brazil: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.2    Brazil: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.5.7.3    Brazil: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.5.7.4    Brazil: Neurological Biomarker Market, by End User, 2018–2027 (USD Million)

10.5.8     Argentina: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.1    Argentina: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.2    Argentina: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.5.8.3    Argentina: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.5.8.4    Argentina: Neurological Biomarker Market, by End User, 2018–2027 (USD Million)

11.          Impact of COVID-19 Pandemic on Global Neurological Biomarker Market

11.1    North America: Impact Assessment of COVID-19 Pandemic

11.2    Europe: Impact Assessment Of COVID-19 Pandemic

11.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4    Rest of the World: Impact Assessment of COVID-19 Pandemic

12.          Industry Landscape

12.1    Overview

12.2    Growth Strategies Done by the Companies in the Market, (%)

12.3    Organic Developments

12.3.1     Overview

12.4    Inorganic Developments

12.4.1     Overview

13.          Company Profiles

13.1    Thermo Fisher Scientific Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    Abbott

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    Myriad Genetics, Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Bio-Rad Laboratories Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    QIAGEN

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Banyan Biomarkers, Inc

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Immunarray Pvt. Ltd.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    Quest Diagnostics Incorporated

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Perkin Elmer, Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 MERCK KGaA

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    Glossary of Terms

LIST OF TABLES

Table 1.             Neurological Biomarker Market Revenue And Forecasts to 2027, By Product(US$ Mn)

Table 2.             Neurological Biomarker Market Revenue and Forecasts to 2027, By Application (US$ Mn)

Table 3.             Neurological Biomarker Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 4.             North America Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.             North America Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6.             North America Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 7.             US Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.             US Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.             US Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 10.          Canada Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 11.          Canada Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 13.          Mexico Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 14.          Mexico Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          Mexico Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 16.          Europe Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 17.          Europe Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 18.          Europe Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 19.          Germany Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 20.          Germany Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 21.          Germany Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 22.          United Kingdom Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 23.          United Kingdom Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 24.          United Kingdom Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 25.          France Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 26.          France Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 27.          France Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 28.          Spain Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 29.          Spain Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 30.          Spain Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 31.          Italy Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 32.          Italy Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 33.          Italy Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 34.          Asia Pacific Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 35.          Asia Pacific Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 36.          Asia Pacific Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 37.          China Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 38.          China Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 39.          China Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 40.          Japan Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 41.          Japan Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 42.          Japan Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 43.          India Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 44.          India Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 45.          India Neurological Biomarker Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 46.          South Korea Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 47.          South Korea Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 48.          South Korea Neurological Biomarker Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 49.          Australia Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 50.          Australia Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 51.          Australia Neurological Biomarker Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 52.          Middle East and Africa Neurological Biomarker Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 53.          Middle East and Africa Neurological Biomarker Market, by Application– Volume and Forecast to 2027  (Million Units)

Table 54.          Middle East and Africa Neurological Biomarker Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 55.          Saudi Arabia Neurological Biomarker Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 56.          Saudi Arabia Neurological Biomarker Market, by Application– Volume and Forecast to 2027 (Million Units)

Table 57.          Saudi Arabia Neurological Biomarker Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 58.          UAE Neurological Biomarker Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 59.          UAE Neurological Biomarker Market, by Application– Volume and Forecast to 2027 (Million Units)

Table 60.          UAE Neurological Biomarker Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 61.          South Africa Neurological Biomarker Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 62.          South Africa Neurological Biomarker Market, by Application– Volume and Forecast to 2027 (Million Units)

Table 63.          South Africa Neurological Biomarker Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 64.          South and Central America Neurological Biomarker Market, by Product – Revenue and Forecast to 2027  (USD Million)

Table 65.          South and Central America Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 66.          South and Central America Neurological Biomarker Market, by End User– Revenue and Forecast to 2027  (USD Million)

Table 67.          Brazil Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 68.          Brazil Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 69.          Brazil Neurological Biomarker Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 70.          Argentina Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 71.          Argentina Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 72.          Argentina Neurological Biomarker Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 73.          Organic Developments Done By Companies

Table 74.          Inorganic Developments Done By Companies

Table 75.          Glossary of Terms, Neurological Biomarker Market

 

LIST OF FIGURES

Figure 1.           Neurological Biomarker Market Segmentation

Figure 2.           Neurological Biomarker Market – By Geography

Figure 3.           Global Neurological Biomarker Market Overview

Figure 4.           Genomic Biomarkers Segment Held Largest Share of Neurological Biomarker Market

Figure 5.           Asia Pacific to Show Remarkable Growth During Forecast Period

Figure 6.           Global Neurological Biomarker Market, By Geography (US$ Million)

Figure 7.           Global Neurological Biomarker Market, Industry Landscape

Figure 8.           Global Neurological Biomarker Market- Leading Country Markets (US$ Million)

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East and Africa PEST Analysis

Figure 13.        South & Central America PEST Analysis

Figure 14.        Expert Opinion

Figure 15.        Neurological Biomarker Market Impact Analysis of Driver and Restraint

Figure 16.        Global Neurological Biomarker Market – Revenue Forecast And Analysis – 2019- 2027

Figure 17.        Global Neurological Biomarker Market – By Geography Forecast and Analysis – 2019- 2027

Figure 18.        Market Positioning of Key Players

Figure 19.        Neurological Biomarker Market Share, by Product, 2019 & 2027 (%)

Figure 20.        Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Neurological Biomarker Market Share, by Application, 2019 & 2027 (%)

Figure 26.        Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.        Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28.        Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.        Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 30.        Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31.        Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 32.        Neurological Biomarker Market Share, by End User, 2019 & 2027 (%)

Figure 33.        Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 34.        Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 35.        Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 36.        North America: Neurological Biomarker Market, by Key Country – Revenue (2019) (USD Million)

Figure 37.        North America Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)

Figure 38.        North America: Neurological Biomarker Market, by Country, 2019 & 2027 (%)

Figure 39.        US: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 40.        Canada: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 41.        Mexico: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 42.        Europe: Neurological Biomarker Market, by Key Country – Revenue (2019) (USD Million)

Figure 43.        Europe Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)

Figure 44.        Europe: Neurological Biomarker Market, by Country, 2019& 2027 (%)

Figure 45.        Germany: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 46.        United Kingdom: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 47.        France: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 48.        Spain: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 49.        Italy: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 50.        Asia Pacific: Neurological Biomarker Market, by Key Country – Revenue (2019) (USD Million)

Figure 51.        Asia Pacific Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)

Figure 52.        China: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 53.        Japan: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 54.        India: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 55.        South Korea: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 56.        Australia: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 57.        Middle East and Africa: Neurological Biomarker Market, by Key Country – Revenue (2019) (USD Million)

Figure 58.        Middle East and Africa Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)

Figure 59.        Middle East and Africa: Neurological Biomarker Market, by Country, 2019 & 2027 (%)

Figure 60.        Saudi Arabia: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

Figure 61.        UAE: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

Figure 62.        South Africa: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

Figure 63.        South and Central America: Neurological Biomarker Market, by Key Country – Revenue (2019) (USD Million)

Figure 64.        South and Central America Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)

Figure 65.        South and Central America: Neurological Biomarker Market, by Country, 2019 & 2027 (%)

Figure 66.        Brazil: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 67.        Argentina: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 68.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 69.        Impact of COVID-19 Pandemic in European Country Markets

Figure 70.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 71.        Impact of COVID-19 Pandemic in Rest of the World Countries Market

Figure 72.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - Neurological Biomarker Market

  1. Thermo Fisher Scientific Inc.
  2. Abbott
  3. Myriad Genetics, Inc.
  4. Bio-Rad Laboratories Inc.
  5. QIAGEN
  6. Banyan Biomarkers, Inc
  7. Immunarray Pvt. Ltd.
  8. Quest Diagnostics Incorporated
  9. Perkin Elmer, Inc.
  10. MERCK KGaA
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the neurological biomarkermarket.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global neurological biomarkermarket, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00003515
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Biomarkers are the molecules that indicate the presence of a disease. The biomarkers of the neurological disorders were not that accessible in earlier days. However, the advancements in the technology have enabled to track the health condition of the brain by measuring the biomarkers. This helps in the earlier detection of disease, less invasive diagnostics and allows faster drug development and is expected to be the effective treatment.

The global neurological biomarkersmarket is being driven by factors such as rising prevalence of neurological diseases and growing focus on neurological biomarker research. Furthermore,increasing awareness of neurological diseases coupled with developing healthcare infrastructure is likely to offer significant opportunities for the growth of the global neurological biomarkersmarket.

The concerns associated with biomarkersis the significant factor that will impede the neurological biomarkers market growth.

Pricing